Artemisinin is an organic chemical compound containing a unique peroxide bridge. It belongs to the group of sesquiterpene lactones. In nature, it can be found in the flowers and stems of sweet wormwood (Artemisia annua). Both artemisinin itself and its semi-synthetic derivatives are among the most popular antimalarial drugs (ACT – artemisinin-based combination therapies). In 2015, the Chinese scientist, Tu Youyou, was honored with half of the Nobel Prize in medicine for research on the antimalarial properties of artemisinin (the second part of the award went to scientists who isolated avermectin).
The effectiveness of artemisinin in combating the protozoa of falciparum parasite (Plasmodium falciparum) and periodontal pathogens that are responsible for gum and mouth diseases (including Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Terponema denticola, Fusobacterium nucleatum) has been scientifically proven. In addition, artemisinin helps to fight borreliosis-causing bacteria, Borrelia burgdorferi, as well as bacteria of the genus Babesia and mycobacterium tuberculosis.
Artemisinin worked well in experimental therapies for diseases induced by chronic inflammation and autoimmune disorders (including RA, SM, SLE). It has been proven that it has a beneficial effect on the immune system and has immunosuppressive activity.
Dosing: no precise guidelines; a standard dose is 400-800 mg a day. It is suggested that supplementation should be continued for a period of 6 to 12 months.